Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Zuraw

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 10, 2018
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary AngioedemaYing Zhang, Michael A Tortorici, Dipti Pawaskar, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
The Journal of Allergy and Clinical Immunology|March 23, 2016
Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthmaMarina Miller, Stephane Esnault, Richard C Kurten, et al.
Allergy and Asthma Proceedings|April 20, 2018
Hereditary angioedema from the patient's perspective: A follow-up patient surveyAleena Banerji, Yu Li, Paula Busse, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 11, 2015
Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin MMarina Miller, Andrew Beppu, Peter Rosenthal, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 21, 2019
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findingsTimothy Craig, William Lumry, Marco Cicardi, et al.
Arerugi = [Allergy]|December 15, 2015
[WAO Guideline for the Management of Hereditary Angioedema]Timothy Craig, Emel Aygören Pürsün, Konrad Bork, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedemaDipti Pawaskar, Michael A Tortorici, Bruce Zuraw, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|July 4, 2012
Clinical impact of peripheral attacks in hereditary angioedema patientsAndy Kusuma, Anurag Relan, André C Knulst, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 10, 2018
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary AngioedemaYing Zhang, Michael A Tortorici, Dipti Pawaskar, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
The Journal of Allergy and Clinical Immunology|March 23, 2016
Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthmaMarina Miller, Stephane Esnault, Richard C Kurten, et al.
Allergy and Asthma Proceedings|April 20, 2018
Hereditary angioedema from the patient's perspective: A follow-up patient surveyAleena Banerji, Yu Li, Paula Busse, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 11, 2015
Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin MMarina Miller, Andrew Beppu, Peter Rosenthal, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 21, 2019
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findingsTimothy Craig, William Lumry, Marco Cicardi, et al.
Arerugi = [Allergy]|December 15, 2015
[WAO Guideline for the Management of Hereditary Angioedema]Timothy Craig, Emel Aygören Pürsün, Konrad Bork, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedemaDipti Pawaskar, Michael A Tortorici, Bruce Zuraw, et al.
Pageof 4